In the field of artificial intelligence, machine learning is a branch that uses data and algorithms to imitate human learning. It's an ongoing process in which computers can improve their accuracy ...

Learn how to use Python scripts to automate repetitive tasks, organize files, process images, and simplify daily workflows.

Fifteen DeFi exploits had already been logged by late March 2026, according to CoinPaprika’s 2026 exploit tracker, and the pace hasn’t slowed since: CertiK’s H1 2026 report counted 344 incidents and ...

Anthropic released FlashProve, an Apache 2.0 zkSNARK prototype that proves a reply came from a committed model without ...

Guido van Rossum wrote Python over a 1989 Christmas break. By 2018 it ran AI and the web, and a fight over the walrus ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

The US-China race for artificial intelligence dominance has entered a new phase: using AI to build better AI. Leading AI companies in the United States and China are increasingly focused on deploying ...

Plus: OpenAI has paused some model work over safety concerns. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.